PT  - JOURNAL ARTICLE
AU  - Zaidi, Abbas
AU  - Lai, Maggie
AU  - Cavenagh, Jamie
TI  - Long-term stabilisation of myeloma with curcumin
AID  - 10.1136/bcr-2016-218148
DP  - 2017 Mar 27
TA  - BMJ Case Reports
PG  - bcr2016218148
VI  - 2017
4099  - http://casereports.bmj.com/content/2017/bcr-2016-218148.short
4100  - http://casereports.bmj.com/content/2017/bcr-2016-218148.full
AB  - Myeloma is a haematological malignancy which typically follows a relapsing-remitting course. While treatment can control the myeloma and improve quality of life for given periods of time, remissions generally become progressively shorter with subsequent relapses, and patients ultimately enter a final refractory phase. To help control symptoms and enhance quality of life, some patients use complementary therapies as an adjunct to their conventional therapy. Here, we describe a myeloma patient who started a daily dietary supplement of curcumin when approaching her third relapse. In the absence of further antimyeloma treatment, the patient plateaued and has remained stable for the last 5 years with good quality of life.